Literature DB >> 303886

Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole.

S I Pelton, P A Shurin, J O Klein, M Finland.   

Abstract

We evaluated the inhibitory effect of trimethoprim (TMP) and sulfamethoxazole (SMZ), alone and in combination, against 34 strains of Haemophilus influenzae. Growth inhibition was determined after incubation for 18 h by comparing viable counts of cultures in drug-containing medium with corresponding counts of control cultures in drug-free medium. In a modified, thymidine-deficient Levinthal broth, the numbers of colony-forming units of all the isolates tested were reduced 100-fold or more by TMP/SMZ (1.25/25 mug/ml) as compared with growth without drug. Inhibition was significantly greater with TMP/SMZ than with either TMP or SMZ alone. Ampicillin-susceptible and ampicillin-resistant strains were equally susceptible to TMP/SMZ. Growth of nontypable strains was inhibited more than growth of type b organisms.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303886      PMCID: PMC429998          DOI: 10.1128/AAC.12.6.649

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Susceptibility of pneumococci and Haemophilus influenzae to antibacterial agents.

Authors:  M Finland; C Garner; C Wilcox; L D Sabath
Journal:  Antimicrob Agents Chemother       Date:  1976-02       Impact factor: 5.191

2.  Haemophilus influenzae apparently resistant to trimethoprim.

Authors:  S R Bushby
Journal:  Br Med J       Date:  1973-07-07

3.  The "in vivo sensitivity test"--bacteriology of middle ear exudate, during antimicrobial therapy in otitis media.

Authors:  V M Howie; J H Ploussard
Journal:  Pediatrics       Date:  1969-12       Impact factor: 7.124

4.  Automated count and size evaluation of colonies of bacteria grown in a zonal concentration gradient of antimicrobial agent.

Authors:  E Yourassowsky; E Schoutens
Journal:  Appl Microbiol       Date:  1974-10

5.  Resistance of Haemophilus influenzae to trimethoprim.

Authors:  J R May; J Davies
Journal:  Br Med J       Date:  1972-08-12

6.  Antimicrobial susceptibility of Hemophilus influenzae.

Authors:  S E McLinn; J D Nelson; K C Haltalin
Journal:  Pediatrics       Date:  1970-05       Impact factor: 7.124

7.  Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media.

Authors:  A E Koch; J J Burchall
Journal:  Appl Microbiol       Date:  1971-11

8.  Ampicillin resistance in Haemophilus influenzae as determined by a rapid test for beta-lactamase production.

Authors:  C Thornsberry; L A Kirven
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

9.  In vitro susceptibility of Haemophilus influenzae to trimethoprim-sulfamethoxazole.

Authors:  L A Kirven; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

10.  Sensitivity of Haemophilus influenzae to antibiotics.

Authors:  J D Williams; J Andrews
Journal:  Br Med J       Date:  1974-01-26
View more
  5 in total

1.  In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.

Authors:  G J Noel; D W Teele
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

2.  Interpretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. The Antimicrobial Susceptibility Testing OC Group.

Authors:  P C Fuchs; A L Barry; S D Brown
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

Review 3.  Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.

Authors:  R de Groot; A L Smith
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

4.  Role of complement in mouse macrophage binding of Haemophilus influenzae type b.

Authors:  G J Noel; D M Mosser; P J Edelson
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

5.  Trimethoprim-sulfamethoxazole therapy of experimental Escherichia coli meningitis in rabbits.

Authors:  J M Mylotte; T R Bates; K A Sergeant; R E Matson; T R Beam
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.